eli lilly retatrutide clinical trials Phase 3 obesity trial results 2026 Eli Lilly Retatrutide Posts 28.3%

Sometimes the switch itself introduces a new adjustment period with temporary worsening before improvement

The most serious side effects include pancreatitis (severe abdominal pain), kidney problems, gallbladder disease, and vision changes

Dont rush to the highest dosea sustainable and effective dose is better than the maximum dose if it means you can stick with the treatment

Patients should inform the scheduling coordinator and procedural team about all medications, including GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists, with specific drug name, dose, and frequency

How does GLP-1R send its signal

Conclusion To wrap up, GLP-1 agonists have emerged as a potent tool in the battle against obesity